EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance. [electronic resource]
Producer: 20200323Description: 16997-17006 p. digitalISSN:- 1091-6490
- Adrenal Gland Neoplasms -- drug therapy
- Animals
- Apoptosis -- drug effects
- Bcl-2-Like Protein 11 -- genetics
- Cell Hypoxia -- drug effects
- Cisplatin -- pharmacology
- Drug Resistance, Neoplasm -- drug effects
- Humans
- Hydroxylation -- drug effects
- Hypoxia-Inducible Factor-Proline Dioxygenases -- genetics
- MAP Kinase Signaling System -- drug effects
- Mice
- Mice, Knockout
- Mutation
- PC12 Cells
- Pheochromocytoma -- drug therapy
- Proteolysis -- drug effects
- Rats
- Von Hippel-Lindau Tumor Suppressor Protein -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.